CyR.WilkinsMD

PubMed

• 2023 Annual Meeting Abstract 178791 retraction.
  Cy R Wilkins> ;Blood. 2024 Mar 17
• 1 citations
  Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
  Vikas, P., Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, Pankil K Shah, Rebecca Zon, Susan Alsamarai, Joy Awosika, Ziad El-Bakouny, Babar Bashir, Alicia Beeghly, Stephani...> ;JAMA Oncology. 2023 Oct 1
• 4 citations
  Romiplostim for chemotherapy-induced thrombocytopenia: Efficacy and safety of extended use.
  Cy R Wilkins, Jocelyn Ortiz, Leah J Gilbert, Shen Yin, Jodi V Mones, Rekha Parameswaran, Simon Mantha, Gerald A Soff> ;Research and Practice in Thrombosis and Haemostasis. 2022 Mar 1
• 4 citations
  Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population.
  Sirish A Kishore, Raazi Bajwa, Layla Van Doren, Cy Wilkins, Gerard J O'Sullivan> ;Current Oncology Reports. 2022 Mar 1
• 27 citations
  Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, len...
  Katrina M Piedra, Tim J Peterson, Carlyn Tan, Jennifer S. Orozco, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Alexander M. Lesokhin, Urvi A Shah, Sydney Lu, Dhwan...> ;British Journal of Haematology. 2021 Aug 15
• 21 citations
  Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience.
  Gerald A. Soff, Jodi V. Mones, Cy Wilkins, Sean M. Devlin, Eva Haegler-Laube, Jonathan Wills, Debra M. Sarasohn, Krishna Juluru, Michael E Singer, Yimei Miao, Jeanette...> ;Research and Practice in Thrombosis and Haemostasis. 2019 May 24
• 48 citations
  A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer.
  Montreh Tavakkoli, Cy Wilkins, Jodi V. Mones, Michael J. Mauro> ;Frontiers in Oncology. 2019 Apr 26
• 46 citations
  Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
  Gerald A. Soff, Yimei Miao, Gemma Bendheim, Jeanette Batista, Jodi V. Mones, Rekha Parameswaran, Cy Wilkins, Sean M. Devlin, Ghassan K. Abou-Alfa, Andrea Cercek, Nancy...> ;Journal of Clinical Oncology. 2016 May 20
• 1 citations
  Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal.
  Tanya B. Dorff, Cy Wilkins, Mehmet Hepgur, David I. Quinn> ;Clinical Genitourinary Cancer. 2014 Apr 1
• Join now to see all

Journal Articles

• Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience  
  Soff GA, Mones J, Wilkins C, et al., Research and Practice in Thrombosis and Haemostasis, 5/24/2019
• Significance of Leukocytosis in Malignancies: A Novel Paradigm Between Leukocytosis, G-CSF, Myeloid-Derived Suppressor Cells and Prognosis.  
  Tavakkoli, M., Wilkins, C., Mones, J. V., & Mauro, M. J., Blood, 11/21/2018
• Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies  
  Li, V. J., Miao, Y., Wilkins, C., & Soff, G. A., Blood 130, no. Suppl 1 (2017): 2324., 12/7/2017
• Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal.  
  Dorff TB, Wilkins C, Hepgur M, Quinn DI, Clin Genitourin Cancer, 4/12/2014
• Join now to see all

Abstracts/Posters

• Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease
  Gerald A. Soff, Debra M. M Sarasohn, MD, Eva S Haegler-Laube, MD, Sean M Devlin, PhD, Yimei Miao, BS, Gemma Bendheim, BA, Jeanette Batista, RN, Jonathan Wills, Jodi V ..., ASH Annual Meeting, San Diego, 12/2/2018

Lectures

• Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018